|
|
| Quarterly Results |
|
| Glaxosmithkline Pharmaceuticals Ltd | | Industry : Pharmaceuticals - Multinational | Chairman : Renu S Karnad | | Home : MNC Asc-Glaxo | Book Value: 91.3566062 | | BSE Code : 500660 | Market Cap: 35356.73 | | NSE Code : GLAXO | P / E : 55.63 | |
| |
|
|
|
|
|
|
| (Rs in Cr.) |
|
|
| Type | 3Qtr | 2Qtr | 1Qtr | 4Qtr | | Net Sales | 804.98 | 953.38 | 738.02 | 782.16 | | Other Income | 28.34 | 28.47 | 54.10 | 38.37 | | Total Income | 833.32 | 981.85 | 792.12 | 820.53 | | Total Expenditure | 750.78 | 666.80 | 596.77 | 615.40 | | Operating Profit | 82.54 | 315.05 | 195.35 | 205.13 | | Interest | 0.32 | 0.43 | 0.28 | 0.65 | | Gross Profit | 82.22 | 314.62 | 195.07 | 204.48 | | Depreciation | 17.11 | 18.11 | 16.36 | 17.18 | | Tax | 31.32 | 90.60 | 52.63 | 56.58 | | Deferred Tax | -11.70 | -9.63 | -4.50 | -0.76 | | Reported Profit After Tax | 45.49 | 215.54 | 130.58 | 131.48 |
|
|
|
|
|